Our Ground Floor Profile is Sky Century Investment (OTC: SKYI)

SKYI is trading right at support levels has a very low float and can move fast spiking to $0.66 highs in August!

OUR NEW PROFILE IS:  SKYI

Sky Century Investment

–Extremely Low Float – just 110 million total shares outstanding and just 50 million unrestricted shares outstanding representing a total market valuation of $9.8 million as of 10/15, 2021 according to OTCMarkets.  

–Virtually Debt Free – SKYI is also virtually debt free with just $277,555 in liabilities.  

–History of Explosive Moves – The stock was trading at $0.40 at the beginning of August and spiked to highs of $0.66 mid-August when some volume came and is currently trading at well-established support levels trading in a range between $0.10 and $0.20.  

–Sitting at $0.10 Support Levels Trading in a Range of $0.10 – $0.20 Over the Past Few Months – SKYI is currently trading at well-established support levels trading in a range between $0.10 and $0.20.  

–2 Months Away from Historically Hot MJ CBD Market Rally – We are entering the Christmas holidays historically the time of year when MJ/CBD stocks heat up and see big moves.  

–Well Established Business in Red Hot Market – SKYI had developed a wide range of top-quality CBD products in three different categories — CBD Isolate, Broad Spectrum CBD and Full Spectrum CBD. 

________________________________________________________________

SKYI HAS DEVELOPED A NEW LINE OF ALL-NATURAL, 100% COMPLIANT CBD PRODUCTS

SKYI HAS ANNOUNCED THE DEVELOPMENT OF A NEW CANNABIS NEWS APPLICATION FOR SMART PHONES AND PCS

__________________________

Good Afternoon Traders,

We could not be more excited for tomorrow; this one is trading right at support levels has a low float and can move very fast. 

Our Exciting CBD Profile is Sky Century Investment (OTC: SKYI)

Sky Century InvestmentSky Century Investment, Inc. (OTC Markets: SKYI) is committed to selling the highest quality CBD products using only pharmaceutical grade ingredients to provide the best product on the market for its customers. Sky Century Investment, Inc. works exclusively with certified suppliers; all products offered by the Company do not contain THC and undergo independent laboratory testing for their chemical composition. 

SKYI has developed a wide range of top-quality CBD products in three different categories — CBD Isolate, Broad Spectrum CBD and Full Spectrum CBD. Full-Spectrum CBD oil contains all of the naturally occurring active cannabinoids derived from hemp (including up to 0.3% THC by weight). Broad spectrum CBD oil is created by taking the full-spectrum extract and further processing it to remove all THC. Broad spectrum products contain the same natural phytocannabinoids, terpenes, vitamins, minerals, fatty acids and lipids as the original hemp plant, just 0% THC. 

It’s easy to get excited about SKYI at current levels; the stock has an extremely low float with just 110 million total shares outstanding and just 50 million unrestricted shares outstanding representing a total market valuation of $9.8 million as of 10/15, 2021 according to OTCMarkets. SKYI is also virtually debt free with just $277,555 in liabilities. The stock was trading at $0.40 at the beginning of August and spiked to highs of $0.66 mid-August when some volume came and is currently trading at well-established support levels trading in a range between $0.10 and $0.20. SKYI already has an established business in CBD as we enter the Christmas holidays historically the time of year when MJ/CBD stocks heat up and see big moves. 

SKY CENTURY INVESTMENT, INC. ANNOUNCES ITS PLANS TO EXPAND ITS CBD PRODUCTS ASSORTMENT

Las Vegas, NV, Aug. 04, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Sky Century Investment, Inc. (OTC Markets: SKYI), a Nevada registered company, committed to selling the highest quality CBD products using only pharmaceutical grade ingredients to provide the best product on the market for its customers, publicly announces its plans to expand its CBD products assortment.

Sky Century Investment, Inc. is pleased to announce that they intend to focus on expanding their product line with CBD content. This decision is made due to the fact that the providing of a wide range of CBD products will be beneficial for both the Company and its customers.

CBD (or Cannabidiol), is one of more than 100 chemicals called cannabinoids that have been identified in the cannabis plant. CBD has been thoroughly studied for its healing properties for medical use; it does not contain the psychoactive compounds that are usually associated with THC. This means that CBD is safe for users in a wide range of age groups.

Sky Century Investment, Inc. emphasizes the key difference between the two main cannabinoids extracted from the cannabis plant; Cannabidiol (CBD) and Tetrahydrocannabinol (THC). CBD is a compound that is legal in most European countries when used as an additive to health and well-being. Sky Century Investment, Inc. specializes exclusively in the legal connections of the CBD, which are legal in most European territories and in other countries outside Europe. The second compound, THC, can be psychoactive and used as part of prescribed medications or for “recreational purposes”. Sky Century Investment, Inc. does not participate in the THC market.

Introducing CBD products to the market, Sky Century Investment, Inc. wants to provide customers with products that are not only effective, but also non-toxic and safe. Based on this motivation, the Company plans to expand its products range in the following areas including:

⁃ The cosmetic line for skin care will be selected to solve various problems, due to the fact that the CBD oil in them has anti-inflammatory, antioxidant and soothing properties.

⁃ Tinctures (therapy for well-being)

⁃ CBD Capsules (food additives, various effects: invigorating effect, sedative effect)

⁃ Gummies (chewing marmalade)

⁃ Disinfectants

⁃ Pet products

The company considers it relevant and necessary to expand and launch a new range of CBD products.

 

“A WORD TO OUR INVESTORS”

Sky Century Investment, Inc. (OTC Markets: SKYI)
March, 2021

Governments around the world are gradually legalizing the production and sale of cannabis, causing an exponential market growth in sales of all derived products. In turn it has led to an increase in market awareness and companies in the industry.   Sky Century Investment is developing products from all three of these categories, ranging from

The said tendency has been most prominent in the US and Canada. In 2016, taxed and recorded sales of legal Cannabis in these countries grew by 30% to $6.7 billion compared to the previous year. Forecasts indicate it will grow to over $20.2 billion by 2022.

The scenario of the explosive growth in North America is expected to take place in Europe as well. The legislation there seems to be following a similar path. This will lead to formation of a substantial legal cannabis market, initially in medical, health and lifestyle with recreational use to follow eventually.

Last June due to the situation Sky Century Investment, Inc. deemed it best to start producing its own line of CBD products. The Company is committed to selling the highest quality CBD products to its customers and select goods for the online store accordingly. The team is dedicated to using only pharmaceutical grade ingredients in the products to provide the best product on the market. All Sky Century Investment, Inc. certified Cannabinoid products are THC free and are independently lab tested for purity.

Sky Century Investment, Inc. highlights the key distinction between two major cannabinoids extracted from the cannabis plant: Cannabidiol (CBD) and Tetrahydrocannabinol (THC). CBD is the compound that is legal in most European countries when used as a health and wellbeing supplement. The Company’s focus is exclusively on Legal CBD compounds which are legal in most European territories and other countries outside Europe. The second compound, THC, can be psychoactive and is used as part of prescribed pharmaceuticals or for “recreational purposes”. Sky Century Investment, Inc. does not and has no intentions to participate in the THC part of the market.

Apart from the quality CBD products, Sky Century Investment also provides a range online services, such as digital marketing and SEO, analytics and reporting. The Company is engaged in content marketing, website design and email marketing. Last year the Company purchased Cannabis News LLC with Cannabis News Application.

Sky Century Investment, Inc. is trading in the open market which means that you can make an investment to fast growing Legal CBD part of the market. Currently the Company is at the last stage of developing its new CBD product line and launching an online store on Shopify platform. It is surely perspective for purchasing SKYI shares seeing that is constantly evolving in all the mentioned areas.

Sincerely,
Nataliia PETRANETSKA
The President of Sky Century Investment, Inc.

SKYI is trading right at support levels has a very low float and can move fast spiking to $0.66 highs in August!

Sky Century Investment, Inc.
skygcbd.com

STOCK INFO
Ticker: SKYI
Shares Outstanding: 110,022,572
Market Valuation: $9,789,808

SKYI has a compelling chart setup: the stock has an extremely low float with just 110 million total shares outstanding and just 50 million unrestricted shares outstanding representing a total market valuation of $9.8 million as of 10/15, 2021 according to OTCMarkets. SKYI is also virtually debt free with just $277,555 in liabilities. The stock was trading at $0.40 at the beginning of August and spiked to highs of $0.66 mid-August when some volume came and is currently trading at support levels trading in a range between $0.10 and $0.20. SKYI already has a well established business in CBD as we enter the Christmas holidays historically the time of year when MJ/CBD stocks heat up and see big moves. 

SKY CENTURY INVESTMENT (OTCMKTS: SKYI) HAS LAUNCHED CANNABIS NEWS APP

Sky Century Investment, Inc., a U.S.-based CBD corporation, informs the public about a recently launch of its first ever application available for Google Play Market. Shortly thereafter, Cannabis News will be available for Apple Store as well.Pot leaf on cell phone

Cannabis News helps users congregate news on cannabis and related topics. With this app, users will be able to discover any and all pieces of news in regard to cannabis from various sources all over the world. The apps functionality is designed to meet the requirements of both regular users and interested investors. People consuming cannabis-based goods will find it useful to get updates on changing legislation of different countries and new products hitting the market. On the other hand, potential investors who are interested in funding cannabis startups will be using Cannabis news to search for new investment opportunities. Moreover, even rival cannabis companies are going to be using the app to monitor trends and tendencies in the industry and closely watch their competitors.

At the moment the app has the following features:

  • monitoring and filtering of all the cannabis news and discoveries 24/7;
  • combining information from numerous existing sources into a convenient feed;
  • creating personal sets of bookmarks based on the desired content;
  • sharing favorite news through popular social media channels;
  • searching through sources via tags.

Cannabis News is constantly being developed to expand the number of available features and increased practicality. Sky Century Investment will be introducing updates to the app in a timely manner. Make sure to be the first one to get them.

Cannabis News is the best solution for those who are interested in cannabis industry and willing to grasp as much information and sources as possible

Download the app below:

AppStore

PlayMarket

SKYI NEWS

.

FOR FULL LIST OF SKYI PRODUCTS CHECK OUT THE COMPANY WEBSITE HERE:

https://skygcbd.com

CBD Oil Tincture Pain / Inflammation / Calmness /Anxiety 1000 mg Limonene 1 fl oz (30ml)
$30.00

BESTSELLERS

Immune Booster 10mg CBD 60ct (capsules)

Disclaimer – This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.

We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates do not hold positions in any stocks covered in this newsletter. Our business model is to receive financial compensation to promote public companies. This compensation is a major conflict of interest in our ability to be unbiased regarding . Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. We expect to be compensated to $10,000 USD to conduct investor relations advertising and marketing for SKYI from a third party Fox Capital LLC. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.

We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, we often employ independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.